Jay Katzman, MD
Gastroenterology · Wayne, NJNPI 1043284227
Payments from drug & device makers
Across 580 payments — averaging $12.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- QOL Medical, LLC$879
- Bristol Myers Squibb$669
- Ferring Pharmaceuticals Inc.$616
- AbbVie$513
- Gilead$348
- plus $969 from 11 others
What the payments were for
- Food & beverage$6,957100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 302 | $2,961 |
| QOL Medical, LLC | 41 | $879 |
| Bristol Myers Squibb | 58 | $669 |
| Ferring Pharmaceuticals Inc. | 54 | $616 |
| AbbVie(2 entities) | 44 | $513 |
| Gilead | 20 | $348 |
| Phathom Pharmaceuticals, Inc. | 17 | $194 |
| Optinose US, Inc. | 11 | $184 |
| Napo Pharmaceuticals Inc | 7 | $144 |
| Exact Sciences | 10 | $137 |
| Johnson & Johnson | 5 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $89 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Shield Therapeutics Inc | 1 | $23 |
| Pfizer | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $11 |
How this compares
$6,957 in reported general payments places this provider in the 75th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine DrMesalamine | 12 | $5,305 |
| Famotidine | 239 | $4,297 |
| Mesalamine | 18 | $3,237 |
| Pantoprazole Sodium | 65 | $1,300 |
| Colestipol Hcl | 22 | $1,254 |
| Omeprazole | 70 | $1,211 |
| CholestyramineCholestyramine (With Sugar) | 15 | $787 |
| Vancomycin Hcl | 11 | $697 |
| Ondansetron OdtOndansetron | 15 | $277 |
| Ondansetron Hcl | 11 | $167 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $147 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Wayne
- Kiran RaoSparta$1.3M
- Adekunle AdeotiIrvington$1.2M
- Carl WallachMorristown$766K
- Vinod RustgiNew Brunswick$697K
- Arvind TrindadeNew Brunswick$652K
- Barry KaufmanEgg Harbor Township$595K
- Promila BanerjeeStratford$522K
- Neil NagariaToms River$442K
- Zamir BrelviNewark$408K
- Adam ElfantMount Laurel$385K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.